Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cholesterol esters regulate apoB48 secretion in CaCo2 cells.

Sebely Pal1, Emma Allister, Andrew Thomson

  • 1Department of Nutrition, Dietetics and Food Sciences, Curtin University of Technology, GPO Box U1987, Perth, WA, Australia.

Atherosclerosis
|March 8, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Special approach of droplet digital polymerase chain reaction (ddPCR) for transgene stability of a Chinese hamster ovary (CHO) cell line.

BioTechniques·2026
Same author

Dual-drug releasing PEG-PLA hydrogels with tunable degradation for sustained local analgesia and anti-inflammatory therapy in a rat fracture/osteotomy model.

Biomaterials·2026
Same author

Imaging zinc speciation in the mouse hippocampus with µXANES Spectroscopic mapping.

Metallomics : integrated biometal science·2026
Same author

Microvascular hypoxia and inflammation in chronic pain syndromes.

Trends in molecular medicine·2025
Same author

A Fast Path from Innovation to Safe and Effective Medicines.

Clinical pharmacology and therapeutics·2025
Same author

Advancing Understanding of Ligneous Conjunctivitis: Bridging Pathogenesis, Diagnosis, and Therapy.

Cornea·2025
Same journal

Optimized flow cytometry assay for functional characterization of variants of uncertain significance in familial hypercholesterolemia.

Atherosclerosis·2026
Same journal

Causal insights of modifiable cardiovascular risk factors for dementia risk - potential for efficient prevention and improved brain health.

Atherosclerosis·2026
Same journal

Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-study.

Atherosclerosis·2026
Same journal

Earliest age to detect lifetime cardiometabolic health stratification in children.

Atherosclerosis·2026
Same journal

Sympathetic neurons exacerbate atherosclerosis by modulating macrophage function via the NPY/Y1R axis.

Atherosclerosis·2026
Same journal

Optimizing lipoprotein(a) testing for immediate clinical impact in primary prevention.

Atherosclerosis·2026
See all related articles

Atorvastatin did not affect apolipoprotein B48 (apoB48) secretion, but accelerated its degradation under certain conditions. Inhibition of cholesterol esterification, however, significantly reduced apoB48 secretion.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Gastroenterology

Background:

  • Apolipoprotein B48 (apoB48) is crucial for chylomicron assembly and lipid transport.
  • Intestinal cholesterol metabolism plays a role in apoB48 secretion.

Purpose of the Study:

  • To investigate the effects of atorvastatin (HMG-CoA reductase inhibitor) and CL277082 (ACAT inhibitor) on apoB48 metabolism in CaCo2 cells.
  • To determine the role of cholesterol synthesis and esterification in regulating apoB48 secretion.

Main Methods:

  • Utilized transformed human intestinal enterocytes (CaCo2 cells).
  • Employed [S35]-methionine pulse-chase experiments to assess apoB48 synthesis and degradation.
  • Quantified apoB48 protein levels using western blotting and enhanced chemiluminescence.

Related Experiment Videos

Main Results:

  • Atorvastatin-induced suppression of cholesterol synthesis did not affect apoB48 production or secretion under basal conditions.
  • Under stimulatory conditions, atorvastatin accelerated apoB48 degradation without altering synthesis or secretion.
  • Exogenous sterols did not impact apoB48 secretion.
  • ACAT inhibition significantly attenuated apoB48 secretion by enhancing its degradation.

Conclusions:

  • Neither endogenous nor exogenous cholesterol acutely modulates apoB48 secretion in intestinal cells.
  • Newly synthesized cholesterol ester appears to be an immediate regulator of apoB48 secretion in CaCo2 cells.
  • ACAT inhibition provides a potential therapeutic target for modulating apoB48 secretion.